ArticleSurgical case reports2025
Thymoma with Intravascular Tumor Thrombus in the Left Brachiocephalic Vein: A Case Report.
Article in Surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advanced thymic epithelial tumours after neoadjuvant therapy: a narrative review of surgical challenges and strategies.Mediastinum (Hong Kong, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThymomas have the potential to locally invade and metastasize, occasionally infiltrating adjacent structures, such as the great vessels and the heart. Although direct extension is the primary mechanism of vascular invasion, rare cases of intravascular growth have also been reported. CASE PRESENTATION: We present the case of a 50-year-old woman diagnosed with a thymoma that extended intraluminally into the left brachiocephalic vein (LBCV), forming a tumor thrombus. The patient was referred to our hospital after chest computed tomography (CT), which revealed an anterior mediastinal tumor with a filling defect adjacent to the superior aspect of the tumor. Initially, the defect was thought to be a blood clot because of the preserved vascular wall structure. However, follow-up CT scans conducted 2 weeks later revealed persistence of the defect and a slight increase in size, leading to the diagnosis of a tumor thrombus. Further imaging, including contrast-enhanced CT and magnetic resonance imaging, confirmed thymoma invasion of the LBCV, necessitating surgical intervention. The patient underwent a median sternotomy and tumor resection with combined partial resection of the LBCV and right upper lobe. Intraoperatively, a dilated thymic vein continuous with the tumor was identified. The tumor thrombus was visible through the LBCV wall, aiding in the determination of its extent. The LBCV was clamped proximally and distally, and the dilated thymic vein was ligated and divided. Subsequently, thymectomy encompassing the tumor and partial resection of the LBCV wall were performed to remove the thrombus. Microscopically, the tumor was classified as a type B2 thymoma. No evidence of continuity between the tumor thrombus and the thymic vein was observed. No postoperative complication was observed. Nine months after surgery, the patient experienced recurrence with pleural dissemination and underwent resection.
conclusionsThymomas can invade vessels through intravascular growth, and contrast-enhanced CT is important for accurately diagnosing such cases. In this instance, preoperative identification of the tumor thrombus enabled a comprehensive surgical approach, resulting in complete resection of the tumor and thrombus, without the need for embolization. This case underscores the significance of meticulous imaging and surgical planning in the management of complex thymomas to ensure optimal patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.